Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial

NCT01239940 is registered in ClinicalTrials.gov with Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular as lead sponsor.

NCT NCT01239940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent). A Prospective, Multicenter and Randomized Clinical Trial
Lead sponsor
Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2010
Completion date
Not reported
Enrollment
310 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

in-stent restenosis